NSUN3 and NSUN4 have received less attention in prostate cancer research, but they may play a role in chemotherapy resistance and tumor advancement (Alshaker et al., 2019), potentially serving as risk factors for prostate cancer (Kar et al., 2016). Here, NSUN3 is linked to prostate cancer.